Advanced glycation end products (AGEs) contribute to diabetic vascular complications by engaging the AGE receptor (RAGE). A soluble RAGE form (sRAGE) acts as a decoy domain receptor, thus decreasing AGE cellular binding. A cross-sectional comparison of sRAGE, asymmetric dimethylarginine (ADMA) plasma levels (index of endothelial dysfunction), and urinary 8-iso-prostaglandin (PG)F2α (marker of oxidative stress) was performed between 86 diabetic patients and 43 controls. Plasma sRAGE levels were significantly lower and ADMA levels were significantly higher in diabetic patients as compared to controls (P < 0.0001). HbA1c and urinary 8-iso-PGF2α were correlated inversely with sRAGE and directly with ADMA. On multivariate analysis HbA1c was independently related to sRAGE levels in diabetic patients. Twenty-four of 86 patients with newly diagnosed diabetes and 12 patients in poor metabolic control were reevaluated after treatment with a hypoglycemic agent or insulin, respectively. Improvement in metabolic control by oral agents or insulin resulted in a significant increase in sRAGE and decrease in ADMA levels (P < 0.0001). Thus, poor glycemic control reduces sRAGE levels, in association with enhanced oxidative stress and endothelial dysfunction in diabetes. These abnormalities are susceptible to modulation by improvement in metabolic control.

Soluble RAGE in type 2 diabetes: association with oxidative stress / E. Devangelio, F. Santilli, G. Formoso, P. Ferroni, L. Bucciarelli, N. Michetti, C. Clissa, G. Ciabattoni, A. Consoli, G. Davì. - In: FREE RADICAL BIOLOGY & MEDICINE. - ISSN 0891-5849. - 43:4(2007 Aug 15), pp. 511-518. [10.1016/j.freeradbiomed.2007.03.015]

Soluble RAGE in type 2 diabetes: association with oxidative stress

L. Bucciarelli;
2007

Abstract

Advanced glycation end products (AGEs) contribute to diabetic vascular complications by engaging the AGE receptor (RAGE). A soluble RAGE form (sRAGE) acts as a decoy domain receptor, thus decreasing AGE cellular binding. A cross-sectional comparison of sRAGE, asymmetric dimethylarginine (ADMA) plasma levels (index of endothelial dysfunction), and urinary 8-iso-prostaglandin (PG)F2α (marker of oxidative stress) was performed between 86 diabetic patients and 43 controls. Plasma sRAGE levels were significantly lower and ADMA levels were significantly higher in diabetic patients as compared to controls (P < 0.0001). HbA1c and urinary 8-iso-PGF2α were correlated inversely with sRAGE and directly with ADMA. On multivariate analysis HbA1c was independently related to sRAGE levels in diabetic patients. Twenty-four of 86 patients with newly diagnosed diabetes and 12 patients in poor metabolic control were reevaluated after treatment with a hypoglycemic agent or insulin, respectively. Improvement in metabolic control by oral agents or insulin resulted in a significant increase in sRAGE and decrease in ADMA levels (P < 0.0001). Thus, poor glycemic control reduces sRAGE levels, in association with enhanced oxidative stress and endothelial dysfunction in diabetes. These abnormalities are susceptible to modulation by improvement in metabolic control.
ADMA; Oxidative stress; RAGE; Type 2 diabetes
Settore MED/13 - Endocrinologia
15-ago-2007
Article (author)
File in questo prodotto:
File Dimensione Formato  
1-s2.0-S0891584907002110-main.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 451.86 kB
Formato Adobe PDF
451.86 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/1045648
Citazioni
  • ???jsp.display-item.citation.pmc??? 36
  • Scopus 131
  • ???jsp.display-item.citation.isi??? 118
social impact